XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES            
Net Loss $ (7,485,198)   $ (6,999,751) $ (29,021,280) $ (23,622,643)  
Adjustments to Reconcile Net Loss to Net            
Stock Based Compensation       3,432,367 4,445,815  
Acquired IPR&D       840,000  
Provision for Bad Debts       99,493 13,087  
Provision for Excess and Obsolete Inventory       1,294,786 717,678  
Change in Fair Value of Warrant Liabilities 624,000   624,000  
Non-Cash Operating Lease Expense       5,062 14,481  
Depreciation and Amortization Expense 897,387   816,158 2,692,692 2,252,317  
Impairment of Inventory   303,568 303,568  
Impairment of Goodwill $ 3,143,000 3,143,200  
Impairment of Contract Assets   1,750,000  
Gain on Sale of Fixed Assets       (9,000)  
(Increase) Decrease in:            
 Accounts Receivable - Trade       849,615 (1,518,823)  
 Inventories       (1,290,029) (256,283)  
 Prepaid Expenses and Other Current Assets       (849,542) 1,066,816  
Increase (Decrease) in:            
Accounts Payable       (980,504) (420,027)  
Deferred Revenue       99,408 (63,661)  
Accrued Other Expenses and Bonuses       1,820,990 129,101  
Net Cash Used in Operating Activities       (15,489,742) (16,947,574)  
CASH FLOWS FROM INVESTING ACTIVITIES            
Purchase of Equipment       (714,697) (2,564,967)  
Purchase of IPR&D       (250,000)  
Net Cash Used in Investing Activities       (964,697) (2,564,967)  
CASH FLOWS FROM FINANCING ACTIVITIES            
Proceeds from Issuance of Common Stock       18,228,000 13,800,000  
Costs of Issuance of Common Stock       (1,334,289) (1,012,130)  
Principal Payment of Finance Leases       (3,354) (54,257)  
Proceeds of PPP Loan       3,191,700  
Payment of Bank Loans       (61,071) (370,800)  
Net Cash Provided by Financing Activities       20,020,986 12,362,813  
Increase (Decrease) in Cash and Cash Equivalents       3,566,547 (7,149,728)  
Cash and Cash Equivalents:            
Beginning   $ 8,810,636   8,810,636 19,271,642 $ 19,271,642
Ending $ 12,377,183   $ 12,121,914 12,377,183 12,121,914 $ 8,810,636
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION            
Cash Paid for Income Taxes       11,300 9,717  
Cash Paid for Interest       103,133 70,368  
SUPPLEMENTAL DISCLOSURE OF NON-CASH OPERATING, FINANCING AND INVESTING ACTIVITIES            
Decrease in Accrued Capital Expenditures       (186,186) (408,299)  
Series B Preferred Stock Issuance for License Agreement       $ 590,000